THALIDOMIDE PHARMION Trademark

Trademark Overview

On Friday, May 9, 2008, a trademark application was filed for THALIDOMIDE PHARMION with the United States Patent and Trademark Office. The USPTO has given the THALIDOMIDE PHARMION trademark a serial number of 77470287. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 22, 2016. This trademark is owned by Celgene Corporation. The THALIDOMIDE PHARMION trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations used to treat cancers and immune related diseases
thalidomide pharmion

General Information

Serial Number77470287
Word MarkTHALIDOMIDE PHARMION
Filing DateFriday, May 9, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 22, 2016
Registration Number3682051
Registration DateTuesday, September 15, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 30, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THALIDOMIDE"
Description of MarkThe mark consists of the words "THALIDOMIDE PHARMION" appearing in black letters to the right.
Goods and Servicespharmaceutical preparations used to treat cancers and immune related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, April 22, 2016CANCELLED SEC. 8 (6-YR)
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 15, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, June 30, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2009NOTICE OF PUBLICATION
Wednesday, May 27, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 27, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 21, 2009DATA MODIFICATION COMPLETED
Tuesday, May 19, 2009ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, April 14, 2009REG. CANCELLED - RESTORED TO PENDENCY
Monday, March 16, 2009ASSIGNED TO PETITION STAFF
Monday, February 23, 2009REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Tuesday, March 10, 2009ASSIGNED TO PARALEGAL
Tuesday, February 17, 2009REGISTERED-PRINCIPAL REGISTER
Monday, January 12, 2009TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 2, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2008NOTICE OF PUBLICATION
Friday, October 24, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 24, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 22, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 2, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 2, 2008LETTER OF SUSPENSION E-MAILED
Thursday, October 2, 2008SUSPENSION LETTER WRITTEN
Wednesday, October 1, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 30, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 30, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 22, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 22, 2008LETTER OF SUSPENSION E-MAILED
Monday, September 22, 2008SUSPENSION LETTER WRITTEN
Tuesday, September 16, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 16, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 5, 2008ASSIGNED TO LIE
Wednesday, August 27, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 26, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 26, 2008NON-FINAL ACTION E-MAILED
Tuesday, August 26, 2008NON-FINAL ACTION WRITTEN
Tuesday, August 26, 2008ASSIGNED TO EXAMINER
Wednesday, May 14, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, May 13, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmion thalidomide immune related diseases cancers treat preparations used pharmaceutical